NY-ESO-1 is a tumor-associated antigen (TAA) and expressed in approximately one-quarter to one-third of lung cancers, melanomas, ovarian cancers, esophageal cancers, bladder cancers, and prostate cancers, and its expression is associated with high-grade tumors. The gene discussed is CTAG1B; the disease is esophageal cancer.